Charlotte, NC, United States of America

Farah K B Mougeot


Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Farah K B Mougeot: Innovator in Oral Health

Introduction

Farah K B Mougeot is a prominent inventor based in Charlotte, NC (US). She has made significant contributions to the field of oral health, particularly in relation to cancer therapy. With a total of 3 patents, her work focuses on understanding and improving the oral microbiome and its implications for patients undergoing cancer treatment.

Latest Patents

Mougeot's latest patents include innovative methods and compositions that address critical issues in oral health. One of her notable inventions is titled "Compositions and methods for oral microbiome signatures." This invention provides methods and compositions involving microbiome signatures and their association with oral complications of cancer therapy. Another significant patent is "Compositions and methods for genetic markers to identify risk of oral mucositis." This invention offers methods and compositions that involve genetic markers and their association with oral mucositis occurring in patients treated with cancer therapy and/or conditioning therapy for hematopoietic stem cell transplantation.

Career Highlights

Farah K B Mougeot is affiliated with the Charlotte-Mecklenburg Hospital Authority, where she applies her expertise in oral health research. Her work has been instrumental in advancing the understanding of oral complications related to cancer therapies.

Collaborations

Mougeot collaborates with esteemed colleagues, including Jean-Luc C Mougeot and Nirav Shah, to further her research and innovations in the field.

Conclusion

Farah K B Mougeot is a trailblazer in the realm of oral health, with her patents paving the way for improved patient care in cancer therapy. Her contributions are vital in enhancing the understanding of oral microbiome signatures and genetic markers, ultimately benefiting patients undergoing treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…